| 3 | Initial statement of beneficial ownershi... | Jensen Michael Wolff | Latham & Watkins Llp (filing Agent) /fa | 03/18/2026 | |
| 3 | Initial statement of beneficial ownershi... | Ascendis Pharma A/s | Latham & Watkins Llp (filing Agent) /fa | 03/18/2026 | |
| 144 | Filing for proposed sale of securities u... | Jensen Michael Wolff | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 12/04/2025 | |
| 144 | Filing for proposed sale of securities u... | Jensen Michael Wolff | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 08/29/2025 | |
| 144 | Filing for proposed sale of securities u... | Ascendis Pharma A/s | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 08/29/2025 | |
| 144 | Filing for proposed sale of securities u... | Ascendis Pharma A/s | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 08/15/2025 | |
| 144 | Filing for proposed sale of securities u... | Jensen Michael Wolff | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 08/15/2025 | |
| 144 | Filing for proposed sale of securities u... | Jensen Michael Wolff | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 05/05/2025 | |
| 144 | Filing for proposed sale of securities u... | Ascendis Pharma A/s | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 05/05/2025 | |
| 144 | Filing for proposed sale of securities u... | Jensen Michael Wolff | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 03/07/2025 | |
| Load More |
SEC Filing Data
